

Pharmaceutical Contract Manufacturing & Contract
Market Scope: Industry Analysis, Market Size,
Growth, Trends Till 2031
Request Sample Report
The Pharmaceutical Contract Manufacturing market is poised for growth, driven by increasing demand for cost-effective production solutions. The global market size exceeded $100 billion in 2022 and is projected to expand at a CAGR of over 8% through 2030, reflecting rising outsourcing trends and innovative drug development initiatives.
Request Sample Report
◍ Catalent
◍ Pharmaceutical Product Development LLC
◍ AbbVie
◍ Baxter BioPharma Solutions
◍ Patheon
◍ Grifols International
◍ Dalton Pharma Services
The Pharmaceutical Contract Manufacturing market features key players like Catalent, AbbVie, and Lonza, offering production, packaging, and R&D services. These companies enhance efficiency and reduce costs, driving market growth. Notable revenues include Catalent at $3 billion, Lonza at $5 billion, and AbbVie at $56 billion, showcasing their industry impact.
◍ Boehringer Ingelheim Biopharmaceuticals
GmBh
◍ Lonza AG.
◍ Grifols S.A
◍ Jubilant Life Sciences Limited
◍ QuintilesIMS
◍ Vetter Pharma
◍ Ligand Pharmaceuticals, Inc.
◍ Bausch Health
◍ Recipharm AB
◍ Famar Health Care Services
Request Sample Report
◍ West Pharmaceutical Services, Inc.
Small Medium Enterprise
Large Enterprise
Request Sample Report
Manufacturing
Research
Request Sample Report
$ X Billion USD